Relationship with spatial memory in diabetic rats and protein kinase Cγ, caveolin-1 in the hippocampus and neuroprotective effect of catalpol

Chinese Medical Journal

Volumn 127, Issue 5, 2014, Pages 916-923

  Zhou, Hai Cheng ^a   Liu, Jing ^a   Ren, Li Yuan ^a,b   Liu, Wei ^a,c   Xing, Qian ^a   Men, Li Li ^a   Song, Gui Rong ^a   Du, Jian Ling ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Friendship Hospital of Dalian   (China)

^c Shenyang First People's Hospital   (China)

Author keywords

Catalpol; Caveolin 1; Diabetic encephalopathy; Protein kinase C

Indexed keywords

CATALASE; CATALPOL; CAVEOLIN 1; GLUTATHIONE; MALONALDEHYDE; PROTEIN KINASE C GAMMA; SUPEROXIDE DISMUTASE; THIOCTIC ACID; IRIDOID; NEUROPROTECTIVE AGENT; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DISEASE; COGNITION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ENCEPHALOPATHY; DOWN REGULATION; HIPPOCAMPUS; LATENT PERIOD; MALE; MORRIS WATER MAZE TEST; NISSL STAINING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIAL MEMORY; WESTERN BLOTTING; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CAVEOLIN 1; DIABETES MELLITUS, EXPERIMENTAL; HIPPOCAMPUS; IRIDOID GLUCOSIDES; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PROTEIN KINASE C; RATS; SPATIAL MEMORY;

EID: 84896888081     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20132137     Document Type: Article

References (38)

1. Biessels, GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus. Diabetologia 1994; 37: 643-650.
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64-74.
3. McCall AL. The impact of diabetes on the CNS. Diabetes 1992; 41: 557-670.
4. Fazeli SA. Neuroprotection in diabetic encephalopathy. Neurodegener Dis 2009; 6: 213-218.
5. Reagan LP. Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications. Exp Neurol 2012; 233: 68-78.
6. Mijnhout GS, Scheltens P, Diamant M, Biessels GJ, Wessels AM, Simsek S, et al. Diabetic encephalopathy: a concept in need of a definition. Diabetologia 2006; 49: 1447-1448.
7. Poon HF, Calabrese V, Scapagnini G, Butterfield DA. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 2004; 59: 478-493.
8. Yang YJ, Wu PF, Long LH, Yu DF, Wu WN, Hu ZL, et al. Reversal of aging-associated hippocampal synaptic plasticity deficits by reductants via regulation of thiol redox and NMDA receptor function. Aging Cell 2010; 9: 709-721.
9. Fukui H, Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 2008; 31: 251-256.
10. Wang Y, Jiang YF, Huang QF, Ge GL, Cui W. Neuroprotective effects of salvianolic acid B against oxygen-glucose deprivation/reperfusion damage in primary rat cortical neurons. Chin Med J 2010; 123: 3612-3619.
11. Nishida S. Metabolic effects of melatonin on oxidative stress and diabetes mellitus. Endocrine 2005; 27: 131-136.
12. Parihar MS, Chaudhary M, Shetty R, Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 2004; 11: 397-402.
13. Wang CF, Li DQ, Xue HY, Hu B. Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats. Brain Res 2010; 1307: 158-165.
14. Caceres LG, Aon Bertolino L, Saraceno GE, Zorrilla Zubilete MA, Uran SL, Capani F, et al. Hippocampal-related memory deficits and histological damage induced by neonatal ionizing radiation exposure. Role of oxidative status. Brain Res 2010; 1312: 67-78.
15. Jiang B, Liu JH, Bao YM, An LJ. Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Toxicon 2004; 43: 53-59.
16. Li DQ, Bao YM, Zhao JJ, Liu CP, Liu Y, An LJ. Neuroprotective properties of catalpol in transient global cerebral ischemia in gerbils: dose-response, therapeutic time-window and long-term efficacy. Brain Res 2004; 1029: 179-185.
17. Li DQ, Bao YM, Li Y, Wang CF, Liu Y, An LJ. Catalpol modulates the expressions of Bcl-2 and Bax and attenuates apoptosis in gerbils after ischemic injury. Brain Res 2006; 1115: 179-185.
18. Lin D, Takemoto DJ. Oxidative activation of protein kinase Cgamma through the C1 domain. Effects on gap junctions. J Biol Chem 2005; 280: 13682-13693.
19. Saito N, Shirai Y. Protein kinase C gamma (PKC gamma): function of neuron specific isotype. J Biochem 2002; 132: 683-687.
20. Liu J, He QJ, Zou W, Wang HX, Bao YM, Liu YX, et al. Catalpol increases hippocampal neuroplasticity and up-regulates PKC and BDNF in the aged rats. Brain Res 2006; 1123: 68-79.
21. Gioiosa L, Raggi C, Ricceri L, Jasmin JF, Frank PG, Capozza F, et al. Altered emotionality, spatial memory and cholinergic function in caveolin-1 knock-out mice. Behav Brain Res 2008; 188: 255-262.
22. Zou W, Wang HX, Liu J, Zhang H, An LJ. Expression of caveolin-1 protein in the rat brain and its role in the discrimination learning. Acta Physiol Sin 2006; 58: 429-434.
23. Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006; 1: 848-858.
24. Baydas G, Donder E, Kiliboz M, Sonkaya E, Tuzcu M, Yasar A, et al. Neuroprotection by alpha-lipoic acid in streptozotocin-induced diabetes. Biochemistry (Mosc) 2004; 69: 1001-1005.
25. Piotrowski P, Wierzbicka K, Smiałek M. Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants. Folia Neuropathol 2001; 39: 147-154.
26. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47-60.
27. Morris RG, Garrud P, Rawlins JN, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982; 297: 681-683.
28. Gong J, Dong J, Wang Y, Xu H, Wei W, Zhong J, et al. Developmental iodine deficiency and hypothyroidism impair neural development, up-regulate caveolin-1 and down-regulate synaptophysin in rat hippocampus. J Neuroendocrinol 2010; 22: 129-139.
29. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003; 26: 770-776.
30. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21: 114-121.
31. Biessels GJ, Smale S, Duis SE, Kamal A, Gispen WH. The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. J Neurol Sci 2001; 182: 99-106.
32. Zhang Z, Gong N, Wang W, Xu L, Xu TL. Bell-shaped D-serine actions on hippocampal long-term depression and spatial memory retrieval. Cereb Cortex 2008; 18: 2391-2401.
33. Mastrocola R, Restivo F, Vercellinatto I, Danni O, Brignardello E, Aragno M, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol 2005; 187: 37-44.
34. Singh PP, Mahadi F, Roy A, Sharma P. Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2. Indian J Clin Biochem 2009; 24: 324-342.
35. Wang Z, Liu Q, Zhang R, Liu S, Xia Z, Hu Y. Catalpol ameliorates beta amyloid-induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors. Neuroscience 2009; 163: 1363-1372.
36. Correia SS, Duarte CB, Faro CJ, Pires EV, Carvalho AL. Protein kinase C gamma associates directly with the GluR4 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit. Effect on receptor phosphorylation. J Biol Chem 2003; 278: 6307-6313.
37. Cameron PL, Ruffin JW, Bollag R, Rasmussen H, Cameron RS. Identification of caveolin and caveolin-related proteins in the brain. J Neurosci 1997; 17: 9520-9535.
38. Ferrarese C, Di Luca M. Biological markers in Alzheimer disease. Neurobiol Aging 2003; 24: 191-193.